Effects of rhg-csf on neutrophil functions and survival in sepsis induced diabetic rats

References

• Sentochnik D E, Eliopoulos G M. Infection and diabetes. Joslin' s Diabetes Meilitus, 13^th ed., C R Khan, G C Weir. Lea & Febiger, Pennsylvania 1994; pp.868–882
   Google Scholar
• Larkin J G, Frier B M, Ireland J T. Diabetes mellitus and infection. Postgraduate Med J 1985; 61: 233–237
   PubMed Web of Science ®Google Scholar
• Gleckman R A, Czachor J S. Managing diabetes-related infections in elderly. Geriatrics 1989; 44: 37–46
   PubMed Web of Science ®Google Scholar
• Reyfield E J, Ault M J, Keusch G T, Brothers M J, Nechemias C, Smith H. Infections and diabetes: The case for glucose control. Am J Med 1982; 72: 439–450
   PubMed Web of Science ®Google Scholar
• Bagdade J D, Stewart M, Walters E. Impaired granulocyte adherence: a reversible defect in host defense in patients with poorly controlled diabetes. Diabetes 1978; 27: 677–681
   PubMed Web of Science ®Google Scholar
• Sato N, Shimizu H. Granulocyte-colony stimulating factor improves an impaired bactericidal function in neutrophils from STZ-induced diabetic rats. Diabetes Care 1993; 42: 470–473
   Google Scholar
• Masuda M, Murakami T, Egawa H, Murata K. Decreased fludity of polymorphonuclear leukocyte membrane in streptozotocin induced diabetic rats. Diabetes 1990; 39: 466–470
   PubMed Web of Science ®Google Scholar
• Wilson R M. Neutrophil function in diabetes. Diabetic Med 1986; 3: 509–512
   PubMed Web of Science ®Google Scholar
• Mowat A G, Baum J. Chemotaxix of polymorphonuclear leukocytes from patients with diabetes mellitus. N Eng J Med 1971; 284: 621–627
   PubMed Web of Science ®Google Scholar
• Valerius N H, Eff C, Hnasen N E, Karle H, Nerup J, Soeberg B, Sorensen S F. Neutrophil and lymphocyte function in patients with diabetes mellitus. Acta Med Scand 1982; 211: 463–467
   PubMedGoogle Scholar
• Sato N, Shimuzu H, Shimomura Y, Uehara Y, Takahshi M, Kobayashi I. Reduced ability of neutrophils to produce active oxygen species in strepzotocin-induced diabetic rats. Exp Clin Endocrinol 1992; 9: 31–33
   Google Scholar
• Kitagawa S, Yuo A, Souza L M, Saito M, Miura Y, Takaku F. Recombinant human granulocyte colony-stimulating factor enhances superoxide release in human granulocytes stimulated by the chemotactic peptide. Biochem Biophys Res Comm 1987; 144: 1143–1146
   PubMed Web of Science ®Google Scholar
• Wichterman K A, Baue A E, Chaudry I H. Sepsis and septic shock: a review of laboratory models and a proposal. J Surg Res 1980; 29: 189–201
   PubMed Web of Science ®Google Scholar
• Brandt L. Adhesiveness to glass and phagocytic activity of neutrophilic leukocytes in myeloproliferative diseases. Scand J Haematol 1965; 2: 126–129
   PubMedGoogle Scholar
• Penny R, Galton D A, Scott J T, Eisen V. Studies on neutrophil function I: Physiological and pharmacological aspects. Br J Heaematol 1966; 12: 623–632
   PubMed Web of Science ®Google Scholar
• Cutler C W, Eke P, Arnold R R, Van Dyke T E. Defective neutrophil function in an insulin dpendent diabetes mellitus patient. J Peridontol 1991; 2(6)394–401
   Google Scholar
• Manouchehr-Pour M, Spagnuolo P, Rodman H, Bissada N. Impaired neutrophil chemotaxis in diabetic patients with severe periodonitis. J Dent Res 1981; 60: 729–733
   PubMed Web of Science ®Google Scholar
• Golub L, Nicoll G, Lacono V, Ramamurthy N. In vivo crevicular leukocyte response to a chemotactic challenge: Inhibition by experimental diabetes. Infect Immun 1982; 37: 1013–1017
   PubMed Web of Science ®Google Scholar
• Brodie D H. Inflammatory cells: Structures & Function. Basic and clinical Immunology, 7^th ed., D P Stites, A L Terr. Appleton, Lebanon 1991; pp: 141–145
   Google Scholar
• Toda H, Murata A, Matssura N, Uda K, Oka Y, Tanaka N, Mori T. Therapeutic efficacy of granulocyte colony stimulating factor against rat cecal ligation and puncture model. Stem Cell 1993; 11: 228–234
   PubMed Web of Science ®Google Scholar
• Daifuku R, Anderson Morstn G. Recombinant methionyl human granulocyte colony-stimulating factor for the prevention and treatment of non-neutropenic infectious diseases. J of An Chemotherapy 1993; 32((Supply A))91–97
   PubMedGoogle Scholar
• Marhoffer W, Stein M, Masser E, Federlin K. Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes. Diabetes Care 1992; 15: 256–260
   PubMed Web of Science ®Google Scholar
• Alexiewicz J M, Kumar D, Smogorzewski M, Klin M, Massry S G. Polymorphonuclear Leukocytes in non-insulin -dependent diabetes mellitus: Abnormalities in metabolism and function Ann Intern Med 1995; 123: 919–924
   Google Scholar
• Davidson J, Sowden J M, Fletcher J. Defective phagocytosis in insulin controlled diabetics: evidence for a reaction between glucose and opsonizing proteins. J Clin Pathol 1984; 37: 783–790
   PubMed Web of Science ®Google Scholar
• Bybee J D, Rogers D E. The phagocytic activity of polymorphonuclear leukocytes obtained from patients with diabetes mellitus. J Lab Clin Med 1964; 64: 1–13
   PubMed Web of Science ®Google Scholar
• Drachman R H, Root R K, Wood W B. Studies on the effect of experimental nonketotic diabetes mellitus on antibactericidal defense: Demonstration of a defect in phagocytosis. J Exp Med 1966; 124: 227–240
   PubMed Web of Science ®Google Scholar
• Esman V. The glucogen content of leukocytes from diabetic and nondiabetic patients. Scand J Clin Lab Invest 1961; 13: 134–137
   PubMedGoogle Scholar
• McColl C E, Caves J, Cooper R. Functional characteristic of human toxic neutrophils. J Inf Dis 1971; 124: 68–75
   PubMed Web of Science ®Google Scholar
• Solberg C O. Neutrophil granulocyte function in bacterial infections. Lancet 1972; 7: 727–730
   Google Scholar
• Stickle J E, Tvedten H W, Schall W D, Smith C W. Adherence of neutrophils from dogs with diabetes meilitus. Am J Vet Res 1986; 47: 541–543
   PubMed Web of Science ®Google Scholar
• Blatmer K S, Mahaffey E A. Neutrophil adherence and movement in poorly and well controlled diabetic dogs. Am J Vet Res 1984; 45(8)1498–1500
   PubMed Web of Science ®Google Scholar
• Bagdade J D, Walters E. Impaired granulocyte adherence in mildly diabetic patients: effects of tolazamide treatment. Diabetes 1980; 29: 309–311
   PubMed Web of Science ®Google Scholar
• Andersen B, Goldsmith G H, Spagnuolo P J. Neutrophil adesive dysfunction in diabetes mellitus: The role of cellular plasma factors. J Lab Clin Med 1980; 111: 275–285
   Google Scholar
• Cairo M S, Rucker R, Bennetts G A, Hicks D, Worcester C, Amile R, Johnson S, Katz J. improved survival of newborns receiving leukocyte transfusion for sepsis. Pediatrics 1984; 74: 887–893
   PubMed Web of Science ®Google Scholar
• Rockow E C, Asciz M E. Mechanisms and management of septic shock: Crit Care Clin 1993; 9: 219–237
   PubMed Web of Science ®Google Scholar
• Young L S. Sepsis syndrome. Principles and Practice of Infectious Diseases, 4^th ed., G L Mandell, J E Bennet, R Dolin. Churchill Livingstone, New York 1995; pp. 690–705
   Google Scholar
• Iguchi K, Inoue S, Kumar A. Effect of recombinant human granulocyte colony stimulating factor administration in normal and experimentally infected newborn rats. Exp Hematol 1991; 19: 352–358
   PubMed Web of Science ®Google Scholar
• Silver G M, O'Reilly M, Mooney D P, I. The beneficial effect of granulocyte colony-stimulating factor (G-CSF) in combination with gentamicin on survival following Pseudomonas burn wound infection. Surgery 1989; 106: 452–455
   PubMed Web of Science ®Google Scholar
• Lindemann A, Herrmann F, Oster W, Haffner G, Meyenburg W, Souza L M, Mertelsmann R. Hematologic effects of recombinant human granulocyte colon-stimulating factor in patients with malignancy. Blood 1989; 74(8)2644–2651
   PubMed Web of Science ®Google Scholar
• Roilides E, Walsh TJ J, Pizzo P A, Rubin M. Granulocyte colony stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils. J Inf Dis 1991; 163: 579–583
   PubMed Web of Science ®Google Scholar